Search CC
Chemours Co
NYSE · CIK 1627223
Last close13.71
Daily change+0.23 (1.71%)
10 Years gain+34.91%
Dividends TTM0.35 (-47.93%)
Dividend yield2.61%
Fundamental Analysis
CC · STANDARD
SIC 2800 · Chemicals & Allied Products · Fiscal year end 1231
Fundamental
33.1Momentum
n/aAcceleration
n/aConfidence
78.0Annual Revenue13
Quarterly Revenue57
Annual CFO13
Balance SheetAvailable
RankingLimited
Score Breakdown
Growth0.0 / 25
Quality7.7 / 25
Capital Efficiency9.8 / 20
Balance Sheet7.3 / 15
Shareholder Economics8.3 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 2.9187 percentage points.
Key Metrics
Revenue Growth TTM-0.92%OK
Revenue CAGR 3Y-5.26%OK
Gross Margin15.29%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0.66%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $5.81B | $902.00M | n/a | $264.00M | $51.00M | 15.53% | n/a | 0.88% | n/a | 150.24M |
| 2025 FY Dec 31, 2024 | $5.78B | $1.14B | n/a | -$633.00M | -$993.00M | 19.75% | n/a | -17.17% | n/a | 150.17M |
| 2025 FY Dec 31, 2023 | $6.08B | $1.30B | n/a | $556.00M | $186.00M | 21.42% | n/a | 3.06% | n/a | 148.91M |
| 2024 FY Dec 31, 2022 | $6.83B | $1.62B | n/a | $755.00M | $448.00M | 23.66% | n/a | 6.56% | n/a | 158.3M |
| 2023 FY Dec 31, 2021 | $6.35B | $1.38B | n/a | $814.00M | $537.00M | 21.77% | n/a | 8.46% | n/a | 168.7M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $5.80B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-065201, 0001627223-26-000011 |
| Revenue Growth TTM | -0.92% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-065201, 0001627223-26-000011 |
| Revenue CAGR 3Y | -5.26% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-065201 |
| Revenue CAGR 5Y | 3.17% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-065201 |
| Gross Profit CAGR 3Y | -17.66% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-065201 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 15.29% | Gross Profit / Revenue | OK | 0001193125-26-065201, 0001627223-26-000011 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001627223-26-000024 |
| Current Ratio | 1.66x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.17x | (Cash + Short-term Investments) / Total Debt | OK | 0001627223-26-000024 |
| Revenue per Diluted Share | $38.33 | Revenue / Diluted Shares | OK | 0001193125-26-065201, 0001627223-26-000011 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001193125-26-065201 |